It was reported that after approximately 14 days of intra-aortic balloon (iab) therapy, a change in patient mentation occurred including seizure activity and stroke alert.Approximately 30 minutes later, while the patient was being transported to ct scan blood was noted in the helium line and the tubing was clamped.The ct results regarding the stroke alert were negative.Approximately four hours later, the iab was removed.The insertion was reported to be right axillary, which is not the method described in the device instructions for use.Approximately six hours after the iab was removed, a new iab was placed via left axillary.It was later reported that another ct scan was taken three days later which showed a new stroke.The patient experienced left-sided weakness.Four days, later the patient was withdrawn from life support and expired.This report is for the second iab used in this event.A separate report was submitted under mfg report number 2248146-2021-00618 for the first iab.
|
The device has not been returned to the manufacturer so we are unable to complete an evaluation.Analysis of production (3331/213) - the device history records review concluded that there were no ncmrs, rework, or deviations documented for the reported lot/serial number.Based on the review results, it was determined that there is no relation between the manufacturing process and the reported failure.Historical data analysis (4109/213) - the review of the historical data was performed.Trend analysis (4110/213) - the overall complaint trend data for the period nov-2019 to oct-2021 was reviewed.Communication/interviews: (4111/213) communication/interviews were performed to obtain all possible information.Reference complaint #(b)(4).
|